Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.
- DOI
- 10.1016/j.bmc.2004.05.041
- Published
- 2004 Aug 1
- Container
- Bioorganic & medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2004.05.041,
title = {Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.},
author = {Smyth TP},
year = {2004},
journal = {Bioorganic \& medicinal chemistry},
doi = {10.1016/j.bmc.2004.05.041},
url = {https://doi.org/10.1016/j.bmc.2004.05.041}
}RIS
TY - JOUR TI - Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors. AU - Smyth TP PY - 2004 JO - Bioorganic & medicinal chemistry DO - 10.1016/j.bmc.2004.05.041 UR - https://doi.org/10.1016/j.bmc.2004.05.041 ER -
APA
TP, S. (2004). Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2004.05.041
Source records
- pubmed · retrieved 2026-09-25T16:57:58.734Z